| Market Cap | ₹13,630Cr |
| ROE | 15.93% |
| P/E Ratio(TTM) | 60.38 |
| EPS(TTM) | 27.57 |
| P/B Ratio | 9.62 |
| Dividend Yield | 0.09% |
| Industry P/E | 40.22 |
| Book Value | 173.03 |
| Debt to Equity | 0.01 |
| Face Value | 5 |
| Parent Organisation | Acutaas Chemicals |
| Managing Director | Mr. Nareshkumar Patel |
| NSE Symbol | ACUTAAS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.66 | ||
| Neuland Laboratories | NA (0.00%) | 85.89 | ||
| Jubilant Pharmova | NA (0.00%) | 36.43 | ||
| Gujarat Themis Biosyn | NA (0.00%) | 88.49 |